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Abstract
Injection drug use is an ongoing urban health crisis in China and one of the largest drivers of the transmission of HIV/AIDS.
Sentinel surveillance sites in Yunnan province show upwards of 20% of injection drug users (IDUs) are HIV positive. Though
the Ministry of Health has scaled-up needle exchange programs (NEPs), they have not received official government
recognition nor have they been extensively evaluated to explore factors influencing their acceptability and feasibility. Using
in-depth qualitative interviews conducted from February to July 2008 with 35 participants consisting of IDUs and other key
stakeholders, we explored facilitators and barriers to accessing needle exchange programs in Kunming, the capital of
Yunnan province. Content analysis was conducted to identify themes including attitudes toward NEPs and harm reduction,
barriers to access, and suggestions for improvement. Themes that emerged included fears of breached confidentiality and
police interference at the exchange sites and tensions between the public health and law enforcement perspective. Low
levels of NEP-related knowledge and awareness were uniformly reported among interviewees. Suggestions to facilitate an
increase in NEP acceptance included raising awareness of harm reduction and HIV more generally, offering services such as
psychological counseling, job training and behavioral therapy at NEPs, and increasing communication between police,
government, and public health officials. High rates of HIV infection among injection drug users in China have prompted
rapid scale up of NEPs. Additional adaptations are necessary, however, to increase needle exchange use among injection
drug users. This study finds that an urgent need to raise awareness of NEPs among policy makers and IDUs and act upon
identified steps for developing social-structural interventions to create enabling environments that facilitate increased
access to NEPs among injection drug users in Kunming.
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Introduction
In 2010, China had 1.35 million registered drug users, though
there are estimated to be a total of 5–8 million [1–4].
Approximately 70–80% of drug users are thought to inject—
predominantly heroin—with nearly 50% of injectors reporting
needle sharing [5–9]. China detected its first AIDS case in 1985,
and in 1989 HIV was diagnosed in an injection drug user (IDU)
living in southern Yunnan [10,11]. Injection drug use fueled
China’s early HIV/AIDS epidemic, and by 2002 HIV infection
had been reported among IDUs in all 31 provinces and
autonomous regions [12–14]. As of 2004, Chinese IDUs had an
average HIV prevalence of 5.4%–8.2% [15], and in 2010, 88,798
registered drug users were HIV positive [5]. However, prevalence
rates vary greatly by region with some sentinel surveillance sites in
Yunnan, Xinjiang, and Guangxi reporting infection rates upwards
of 75–89% among IDUs [5,13,16].
Harm reduction is a strategy to reduce the negative health,
social, and economic effects of drug use, (e.g. the spread of blood-
borne diseases), without requiring abstinence from drugs [17,18].
Harm reduction has been particularly successful in lowering HIV
rates within IDU-driven epidemics in cases where implementation
and scale-up is swift [19,20], and can include needle exchange,
methadone maintenance treatment (MMT), peer education, and
condom promotion. Though innovative mechanisms to provide
clean needles (e.g. mobile clinics, vending machines and safer
injection sites) have proven efficacious in other countries [21,22],
options in China are limited to the provision of sterile needles/
syringes through exchange sites and peer educators [23]. In its
expanded form, needle exchange programs (NEPs) can become a
means of providing integrated health care, educational services,
and referrals to drug treatment and HIV testing [24,25]. NEPs
have been evaluated within international settings and China itself,
and found effective in preventing the acquisition of HIV and other
blood-borne pathogens without increasing levels of drug use,
discarded syringes, or crime [20,26–29]. China began its first NEP
in 2000 as a trial effort between local governments and
international donors, and found it to be remarkably successful in
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lowering needle sharing and rates of Hepatitis C transmission
[30,31].
Though NEP and MMT are both considered pillars of harm
reduction strategies, in China NEPs have not received the same
amount of government support as methadone. Though national
NEPs have been scaled up since 2004 [32] and are mentioned in
China’s second 2006–2010 action plan [30], there is no
straightforward policy within Chinese written law and the ministry
of public security has never officially sanctioned NEPs [1,30].
These tensions highlight a potential conflict between the concept
of harm reduction and the ways in which it is implemented and
sustained. From a health perspective, NEPs are used to discourage
needle sharing and lower the transmission of blood-borne diseases.
From a security perspective, drug use is criminal and should be
eliminated, and IDUs should be detained. As a result, NEPs are
viewed as condoning drug use from a security perspective, but seen
as beneficial in public health terms [20].
Within China, NEPs are only partially supported by govern-
ment funding—international organizations provided 43% of
funding for NEPs in 2004—in comparison to methadone clinics
which are fully subsidized by the Chinese government [32]. This
lack of formal support complicates implementation and compro-
mises program success [20,30,31]. By 2008 there were 729 NEP
sites located throughout China [30,32] that were estimated to be
reaching approximately 2% of all IDUs in the country [26,33], or
close to 40,000 IDUs [34]. Previous studies in China have
attributed these low NEP attendance rates to lack of awareness of
the service, limited choice in the types of needles provided,
inconvenient hours and locations, and fear of police arrest
[32,35,36]. The high HIV prevalence in this population, coupled
with the low percentage of IDUs using NEPs, highlights the
importance of addressing injection drug use and incorporating
harm reduction measures into public health policy within China.
In this paper we examine perceptions and attitudes among
Chinese IDUs and other key stakeholders toward harm reduction
services as well as the facilitators and challenges to accessing NEPs
in particular. Key stakeholders include peer educators (often
former drug users serving as outreach workers), MMT clinic staff,
and program staff of organizations working on HIV and drug use.
This study aims to fill the gap of qualitative research knowledge to
inform ways in which public health professionals develop culturally
appropriate interventions to increase access and retention at NEPs
in China.
Setting and Methods
The research was conducted in Kunming City, Yunnan
Province, a city of 3 million people in southwestern China [37].
Yunnan Province borders Burma, Laos, and Vietnam, which
make up the ‘Golden Triangle’, one of Asia’s main opiate
producing regions. As of October 2007, 40,000–50,000 people in
Yunnan were HIV-positive [5], 65% of whom were infected
through sharing non-sterile syringes [38].
From February-July 2008, 20 IDUs were recruited through
NEPs, a drug rehabilitation center, and methadone clinics, and
were deemed eligible to participate if they were at least 18 years
old and had self-reported drug use in the last year. Additionally, 15
key stakeholders were recruited from local and international non-
governmental organizations (NGOs) working on issues of drug use,
HIV/AIDS, or harm reduction, and included individuals working
as peer educators, program coordinators, and drug rehabilitation
and methadone clinic staff.
Purposive sampling was used to recruit individuals who had
experience with injection drug use, needle exchange programs,
and harm reduction more generally, and could thus provide
insight into knowledge and barriers surrounding access to harm
reduction programs. In this instance it was used to recruited
current and former injection drug users who could speak to
accessing and using needle exchange programs, as well as NGO-
staff and policy makers who could address to the broader socio-
political context.
Data Collection and Analysis
Qualitative data collection methods were used to elicit detailed
narratives about participants’ experience with drug use and harm
reduction without imposing pre-existing assumptions [39–41].
Written informed consent was obtained from each injection drug
user, and oral consent was obtained from each stakeholder. Oral
consent consisted of reading the consent document aloud to the
participant, asking if they had any questions, and then asking if
they were still willing to proceed with the study. If they agreed, the
researcher initialed and dated the oral consent form. This study
was approved by Institutional Review Board at the Chinese
Centers for Disease Control and Prevention. The IRB approved
verbal consent for stakeholders since these stakeholders were
speaking about their professional experiences in the fields of HIV
and drug prevention and drug policy (as opposed to the drug users
who were speaking about personal experiences). Interviews were
semi-structured yet allowed for additional probes when salient
topics arose. The interview guide focused on the following topics:
the role of drug use in Chinese history, how an individual began
using drugs or first became involved in the field of drug
prevention, perceptions of harm reduction and NEPs, facilitators
and barriers to access and use, experience (if any) with detention,
drug cessation, NEPs, or methadone, understanding of local and
national-level drug policies, and suggestions for further improve-
ments. Specific questions included: 1) Please tell me about the first
time you used drugs; 2) Have you ever tried to stop using drugs?
Can you tell about what you did; 3) What have you heard about
needle exchange programs? Please tell me about any personal
experience you have with these; and 4) Have you ever had any
interactions with police as a result of your drug use? If so, please
describe to me what happened. The first author conducted
interviews in private locations including rehabilitation centers,
NGO offices, and places of work. The IDU participants were
compensated 25 Chinese Yuan (,$4) for their time.
Interviews were conducted in Mandarin Chinese, digitally
recorded, and ranged from 35–75 minutes (average 45 min).
Native Chinese speakers conducted verbatim transcription and
translation, with translations validated by bilingual individuals.
Digital files were destroyed after transcription. A ‘‘do not
translate’’ list including street jargon and slang was created to
preserve the meaning of key concepts in the original Chinese.
Thematic analysis focused on accessing and using NEPs in the
Chinese context, structural facilitators and barriers, and sugges-
tions for future improvement. Transcripts were first hand-coded
by the authors who, after reading a subset of transcripts, created a
preliminary codebook containing key categories. These codes were
applied to ten interviews to ensure applicability and allow for the
creation of more nuanced versions of the codes. The remaining
interviews were hand coded then uploaded into ATLAS.ti [42]
and electronically coded. Any discrepancies were discussed among
investigators and resolved.
Results
The mean age for IDUs was 35 years (range 26–43) and 36
years for NGO staff (range 29–55). Of the IDUs interviewed 55%
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had completed high school whereas among NGO staff participants
the rate of high school completion was 67% (among whom 40%
completed college or higher). Of the 20 IDUs, approximately half
reported ever attending a needle exchange program, as did 2 of 5
peer educators (who were previous injectors). Nearly all NGO staff
reported daily interactions with IDUs, and half interacted
regularly with a needle exchange program. Though IDUs and
NGO staff differed widely in their education and professional
history, their beliefs regarding challenges to harm reduction
utilization in China were similar. As a result, data from IDUs and
NGO staff were combined for analysis.
In data analysis, three general themes emerged: 1) general
responses to drug use, harm reduction and needle exchange
programs, 2) challenges to access and uptake, and 3) suggestions
for improving existing services. These themes are described below.
General Responses to Drug Use and Harm Reduction:
Drugs as a part of colonial history. The majority (85%) of
individuals interviewed supported harm reduction because of its
demonstrated ability to decrease levels of blood-borne infections,
reduce crime, and help IDUs integrate into society. However,
participants stressed the specificity of the Chinese context and how
the broader cultural-historical framework must be taken into
account when discussing drug use and harm reduction. More
specifically, drug use was framed against a backdrop of the opium
wars that China conducted with Britain in the 1800s. As one NGO
worker described:
‘‘The culture is a barrier to harm reduction due to China’s
relationship with drugs, especially heroin. This is a
Confucian society and there is a historical barrier to drug
use based on its association with the western powers, [that
of] humiliation and control. The Korean and British
kingdoms around China have for hundreds of years used
drugs as a way to sedate China.’’ (NGO_Male_37)
Conflicting views on needle exchange programs. Many
participants pointed out the importance of needle exchange
programs in reducing infectious disease transmisison:
‘‘In Kunming, there are many HIV-infected individuals due
to the sharing of needles. When they exchange needles they
want to save money on buying new needles; people don’t
like to spend that money. If you use mine [needle] and I use
yours, it’s not very healthy.’’ (NGO_Female_30)
In contrast, one IDU noted that although he would support
methadone because it required people to stop drug use, which he
felt would have a positive influence on law and order, he was wary
of NEPs:
‘‘Methadone is definitely more effective because it encour-
ages everyone to quit using drugs. If drug abuse spreads it
creates a problem for public security, which will lead to
social turmoil. Providing needles alone in the context of
needle exchange is a way to encourage drug using. It’s like
saying, you use drugs? No fear, come to us if you need more
needles.’’ (IDU_Male_40)
The majority of participants expressed strong support for NEPs,
citing that many IDUs were not ready or able to quit. Others
pointed out that NEPs filled an important gap in locations where
pharmacies are unwilling to sell needles to drug users, or when
IDUs are unable to afford new needles. As one individual noted:
‘‘Needle exchange is definitely successful. Based on my
personal experience, and the experience of people around
me, if you have money to buy drugs, there would be no
money to buy needles, so you share, which could lead to
serious consequences….So it solves both psychological and
financial burdens.’’ (IDU_Male_40)
Challenges to the use and scale up of NEPs
Though the majority of individuals supported harm reduction
and noted the importance of NEPs, they discussed numerous
challenges to their use and scale-up. The most salient barriers
included lack of knowledge about NEPs among IDUs and fears
regarding confidentiality and police interference.
Lack of awareness about NEPs. Even though participants
in this study were recruited through NGOs, rehabilitation centers,
and methadone clinics, a number of IDUs reported not knowing
NEPs existed in their area or how they function.
‘‘They don’t know about it. The program is not offered in
many areas, and many people have never heard of such
things. They just don’t know about it – it’s not that they
don’t want to participate in it.’’ (IDU_Male_36)
In addition, many reported that their friends did not take blood-
borne diseases seriously, and that the benefits of attending an NEP
was outweighted by other risks they faced such as arrest or
incarcertation:
‘‘They [IDUs] distrust the government and wonder if they
will get caught or not. If they were arrested for only a couple
of needles it wouldn’t be worth it…I think there is the
problem of not taking it too seriously. Most do not realize
this disease’s severity, so for them, the topic is a boring topic.
If they bought one needle and used it for 5 days, it’s not as
troublesome as buying a new one each time.’’ (IDU_-
Male_32)
In addition to increasing knowledge of NEPs among IDUs and
increasing the number of NEP distribution sites, participants also
said that NEPs should be managed in ways that make the services
more accesible to IDUs. Maintaining NEPs in convenient
locations with extensive hours was considered important because,
as one NGO official noted, IDUs are only willing to travel so far to
access services:
‘‘My feeling is that [the government] is doing an incredible
job of scaling up hardware more so then software and that
they are outpacing all other places in the world. However,
they build these centers but it doesn’t mean people will
come. We have it and it’s not used. They need to be in safer
zones, the times are a problem, and the location. If I’m a
drug user I’m not going to get on a bus for one and half
hours or pay for a taxi. If it closes at 5pm I can’t help it.’’
(NGO_Male_37)
Concern with Confidentiality. A recurring theme described
by IDUs and NGO workers was the fear that presenting at an
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NEP would serve to disclose an individual’s status as a drug user,
which could lead to discrimination, stigmatization, or arrest. Well
over two-thirds of participants mentioned this fear. As one IDU
explained:
‘‘Some people are skeptical. They don’t trust the govern-
ment and other social organizations. They are afraid that
others might find out that he is a drug addict. I haven’t
participated, because personally I am afraid that others will
know that I am still abusing drugs.’’ (IDU_Male_36)
A peer educator noted that in order to ensure confidentiality,
NEPs should be mobile and go to wherever IDUs are, whether
that means meeting them in their house, a shooting gallery, or
specified street-corner.
Police and Public Security. The most consistently reported
barrier to accessing NEPs was interference of NEP operations by
local police security authorities. NGO staff stressed the need for
policy makers to create new laws to address these challenges, and
injection drug users spoke of a need for education and training
among police. Specific barriers include police harassment and fear
of targeted arrests by police waiting for clients to leave NEPs.
According to these comments, arrests are more common toward
the end of the month. As one individual explained:
I think the main barrier is the public security bureau. No
matter how good the relationship is between the Center for
Disease Control and the Public Security Bureau, there will
be tension. I have heard plenty of stories of the police
hanging out outside of clinics and arresting people… So that
is a huge problem. People are afraid to present at the harm
reduction places when the cops are around, and it also limits
outreach that can be done into the drug using community.
(NGO_Male_53)
An IDU echoed this problem of police interference and how it
deters people from presenting at harm reduction facilities, but also
stressed how the government can work to eliminate this barrier.
‘‘There are police watching and waiting to arrest people. It’s
embarrassing if you got caught while exchanging needles
and most of my friends do not like to go because the police
might find out. It’s not worth it because on needle only costs
1 or 2 Yuan (,12–25 cents). It would be best if the police
didn’t go interfering because they scare everyone off…The
government gives the police too much pressure to arrest
some number of people in a certain amount of time, they
can’t help but look everywhere to find the needle exchange
programs. It doesn’t matter if you’re injecting or exchang-
ing, they will arrest you as long as they see you.’’
(IDU_Male_45)
Though this IDU noted how the government might work to
eliminate this barrier, those interviewed did not express faith that
the government wished to eliminate these types of barriers. Both
NGO-level staff and IDUs described police presence as a barrier
that strongly influenced the ability to provide, and access, clean
needles. Nearly all individuals we spoke with felt strongly that both
national and local level policy must be better harmonized in order
to provide effective services, and that what was occurring on the
ground should match the stated policies. As one individual noted:
‘‘It (NEP) is a very successful intervention. But it’s a very
contradictory subject because on one hand, the government
has put in a lot of funding to maintain this program and
prevent HIV transmission, but on the other hand, the police
department is attacking it. Isn’t it ironic.’’ (NGO_Fe-
male_38)
Suggestions for improving access to NEPs
Participants raised various suggestions for improvement of
NEPs, including facilitating discussions between the national
government and security bureau, increasing awareness of NEPs
among both IDUs and the general community, and providing a
broader array of social services for IDUs. Many cited the
discrepancy between the positions of the ministry of health and
the police, noting the need for closer cooperation between the two.
As one individual explained:
‘‘There is a very different view in China than in the U.S. For
example we think of harm reduction as being there to lower
levels of HIV/AIDS, but here, it is more a question of public
order and control as opposed to health. They want to get
people off drugs and are not so worried about whether they
might get infected.’’ (NGO_Male_52)
This individual’s sentiments suggests that, on some level, China
is more focused on maintaining control of the flow of drugs, and
those who choose to use them, than the potential public health
ramifications. This belief may stem from a disconnect in the rapid
scale-up of methadone clinics in China in comparison to a relative
lack of support for NEPs; it may also reflect the power the public
security bureau has in policy formation and implementation as
opposed to the CDC and public health focused organizations. This
tension between public security and public health was consistent
throughout the interviews.
Many of the NGO staff felt strongly about the need to link drug
users accessing one type of harm reduction treatment to other
harm reduction alternatives (e.g. needle exchange programs to
methadone), in order to move them along a path toward cessation.
This included working directly with the rehabilitation centers to
inform drug users of available community services incase of
relapse, and linking methadone and NEPs so IDUs knew of
available options when they were ready to stop using drugs. As one
individual in the NGO sector described:
‘‘First we do the needle exchange, and then I will tell them
about methadone to quit drugs. I will tell them to quit and
drink methadone every time they are here, but they are
sometimes unwilling to listen. We have to be patient and
explain to them one step at a time, then they will listen.’’
(NGO_Female_43)
Some interviewees felt that in addition to needle exchange and
methadone maintenance, there was an unmet need for psycho-
social support and job training for those seeking work following
recovery from addiction.
‘‘There should be a psychiatrist to go to when you are
feeling depressed or sad while using drugs. There should be
someone who understands you…to help us to find a job and
to seek emotional help. We are already isolated from society,
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so it would be most beneficial if they could provide us
employment opportunities.’’ (IDU_Male_45).
Discussion
Based on our knowledge, this is the first qualitative study to
examine attitudes and barriers towards needle exchange programs
in Kunming, China. Interviews with current and former drug
users and NGO workers can better inform our understanding of
how these groups perceive barriers such as lack of knowledge
among IDUs, police, and policy makers, confidentiality concerns,
and police interference, as well as ways in which they feel such
programs would be improved.
Reports of stigma and discrimination are common among drug
users, and though media campaigns have been conducted to
improve awareness surrounding HIV/AIDS and drug use,
knowledge and acceptance of NEPs remain low among commu-
nity members [30]. Though acceptance of NEPs is high among
IDUs, and many report wanting to access them, there is a fear that
it may result in incarceration. Both NGO-staff and IDU
respondents suggested raising community and IDU awareness,
and in turn hopefully lowering stigma through media and school-
based campaigns, collaboration with community leaders, and
families of IDUs. Studies have found that IDUs who are more
aware of the benefits of harm reduction are more likely to
participate [18,43,44]. Numerous NGO participants also suggest-
ed providing information about harm reduction services to drug
users in detoxification centers since relapse rates are close to 95%
and IDUs are often unaware of harm reduction services, a strategy
widely supported by studies of post-release relapse and recidivism.
[20,45,46]. The provision of information within detention centers
could include having local NGOs offer information about their
services in case detainees need additional post-release assistance,
with a focus on support groups, NEPs and methadone programs.
Discrimination of IDUs remains high in China, and many IDUs
expressed reluctance to attend harm reduction centers due to the
lack of confidentiality and fear that others would discover their
status as a drug user [18,43,47,48]. Some programs have tried to
address issues of confidentiality by having mobile vans serve as
NEPs, or even NGO-members who carry clean needles in their
backpacks and go directly to the houses of drug users to exchange
needles [21,22,49]. Others also feared arrest and harassment by
police who might identify them through their attendance at harm
reduction services. A Burnet Institute Report noted that 10–30%
of IDUs spend time in a mandatory detoxification center each year
[50], and studies in the United States have reported similar
barriers to harm reduction: punitive eligibility requirements, fear
that attendance will reveal one’s IDU status, and fear that NEPs
may lead to increased loitering and the creation of heroin markets
near clinics [51,52].
Many who were interviewed felt that an advantage of NEPs was
their appeal to current users, which could be an important tool for
delivering other harm reduction services to this hard to reach
population. Some suggested integrating NEPs and methadone
clinics at the same location so center staff could build rapport with
IDUs while exchanging needles and socialize them to the concept
of methadone maintenance through staff they know and trust.
Previous studies in China have found that IDUs perceive NEPs to
be less risky than methadone because NEPs allow them to
participate from within the community and without registration
[31,53]. This situation makes NEPs particularly effective for
initiating contact with IDUs without an arrest record, and it can
also facilitate accessing marginalized IDU groups such as
minorities and migrants [20,31]. Greater links between NEPs
and MMT programs can function as two-way referrals for IDUs
seeking methadone treatment as well as those patients who drop
out of methadone programs [31,54].
Participants also emphasized the importance of additional
services including job training skills, housing support, and
psychological counseling. Psychological support and therapy is
important for both its emotional benefits and its ability to increase
effectiveness and retention rates within harm reduction centers
[48,55,56]. Though the social work sector in China is still
relatively underdeveloped many respondents felt strongly that they
would benefit from such services [19,43].
The most commonly discussed problem among respondents
related to law enforcement and fear of arrest [57]. Law
enforcement as a barrier to accessing harm reduction services
has been reported in numerous settings including Russia, China,
Canada, Vietnam, and the United States [13,32,47,58–60]. An
evaluation of fifteen NEPs in China found that police attitudes
affected rates of needle turnover, and that NEP staff and police
must work closely to facilitate IDUs’ use of NEPs [32]. Though
health officials endorse harm reduction, support for harm
reduction is limited at high levels of the government and among
public security authorities who see it as condoning drug use
[26,32]. This has translated into police practices on the ground in
which officers target drug users not only for reasons of public
security but also in response to pressure from superiors to meet
arrest quotas [26,37,53]. Many studies have shown police support
for total abstinence (as opposed to harm reduction), as a result, one
approach to working with the public security bureau could be to
emphasize that participation in a syringe access intervention often
facilitates cessation [24,25,54,61]. Another approach might be
facilitating national-level dialogue between the public service
bureau and Centers for Disease Prevention and Control to assess
how best to address both public health and policing needs.
The aforementioned barriers highlight an ongoing tension
between advocates of harm reduction, who see it as a means of
lowering blood borne illnesses, and those who see it from a security
perspective and as something that should be handled through
criminalization [20]. Though the central government has pushed
for increased cooperation between the involved ministries—public
security, justice, education, health—implementation varies greatly
at the local level [20,30,62], highlighting the need for support at
each level of government. Support from high-level leaders is
especially important in China due to its highly centralized policy
development process and decentralized implementation process
[31]. A lack of consensus among public security leaders, however,
has resulted in ambiguous statements regarding harm reduction,
which has contributed to confusion at a local level regarding how
officials should implement policy [53]. Studies have also suggested
working with the Chinese government—specifically local and
provincial leaders—to increase understanding of drug use and
focus on a more treatment-oriented approach rather than
punishment [13,26,63].
One limitation of this study is that some interviewees did not
have extensive knowledge of harm reduction interventions. Also,
although we conducted interviews across various organizations,
and varied between those who interacted daily with IDUs and
higher-level coordinators, we were unable to interview any police
or detention facility personnel. We worked with the NGO in
Kunming to reach out to such officials but none were willing to
participate. Although this study was only conducted in one city in
southwestern China, the results align with existing studies from
other countries, suggesting its salience. Due to the exploratory
nature of the study and, we focused on applying a thematic
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analysis to understand emergent concepts as opposed to grounding
the research in a already existing conceptual framework. Though
we did not use a theoretical sampling framework, certain themes
were repeatedly mentioned across participants, suggesting that the
data had reached saturation and the results were meaningful. In
addition, these themes were generated through both IDU and
other stakeholder perspectives, which enhances credibility.
Findings from this study suggest that while the Chinese Ministry
of Health’s support of harm reduction has been a positive step
forward, additional work is required to scale-up NEPs and
encourage attendance among IDUs. Respondents believe it is
crucial to address an underlying wariness toward NEPs, and to
have the policy makers, public security bureau, and NGOs
increase their levels of coordination to help facilitate the privacy of
IDUs attending these clinics, and lower their fears of arrest.
Facilitating dialogue and collaboration between the ministry of
health and public security bureau and increasing awareness may
move critical interventions forward. In the meantime, existing
NEPs throughout China will continue to provide services to IDUs
in the effort to lower rates of drug use and help stem China’s HIV
epidemic.
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